Tivic reports fiscal year 2023 financial results

San francisco--(business wire)--tivic health® systems, inc. (“tivic”, nasdaq: tivc), a health tech company that develops and commercializes bioelectronic medicine, today announced its financial results for the year ending december 31, 2023. tivic's commercial platform is a handheld design that interfaces non-invasively with the trigeminal, sympathetic, and other facial and cranial nerve structures. this platform is the basis for tivic's existing product, currently marketed with fda approval as.
TIVC Ratings Summary
TIVC Quant Ranking